Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning

DB Bylund, HS Blaxall, LJ Iversen, MG Caron, RJ Lefkowitz and JW Lomasney

Department of Pharmacology, University of Nebraska Medical Center, Omaha 68198-6260.

On the basis of extensive radioligand data and more limited functional data, three pharmacological subtypes of alpha 2-adrenergic receptors have been identified. More recently, three human genes or cDNAs for alpha 2-adrenergic receptors have been identified by molecular cloning. The relationship, however, among the pharmacologically defined subtypes and those identified by molecular cloning has not been clear. In order to resolve this issue, we have compared the pharmacological characteristics of the receptors identified by molecular cloning and expressed in COS-7 cells with the characteristics of the pharmacologically defined receptors in their respective prototypic tissue or cell line. The affinities (Ki values) of 12 subtype-selective alpha 2-adrenergic antagonists were determined for the alpha 2 receptor in the six preparations, by radioligand binding. Correlation analyses of the pKi values indicate that the alpha 2A subtype, as defined in the HT29 cell line, the alpha 2B receptor of the neonatal rat lung, and the alpha 2C subtype, as defined in an oppossum kidney cell line, correspond to the cloned human alpha 2-C10, alpha 2-C2, and alpha 2-C4 receptor subtypes, respectively.

Volume 42, Issue 1, pp. 1-5, 07/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				M. Aihara, J. D. Lindsey, and R. N. Weinreb Effect on Diurnal Intraocular Pressure Variation of Eliminating the {alpha}-2 Adrenergic Receptor Subtypes in the Mouse Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 929 - 933. [Abstract] [Full Text] [PDF]

				S. A. Bavadekar, G. Ma, S. M. Mustafa, B. M. Moore, D. D. Miller, and D. R. Feller Tethered Yohimbine Analogs as Selective Human {alpha}2C-Adrenergic Receptor Ligands J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 739 - 748. [Abstract] [Full Text] [PDF]

				T.-a. Koshimizu, G. Tsujimoto, A. Hirasawa, Y. Kitagawa, and A. Tanoue Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human {alpha}1D- and {alpha}1B-adrenergic receptors Cardiovasc Res, September 1, 2004; 63(4): 662 - 672. [Abstract] [Full Text] [PDF]

				J. O. Ruuskanen, H. Xhaard, A. Marjamaki, E. Salaneck, T. Salminen, Y.-L. Yan, J. H. Postlethwait, M. S. Johnson, D. Larhammar, and M. Scheinin Identification of Duplicated Fourth {alpha}2-Adrenergic Receptor Subtype by Cloning and Mapping of Five Receptor Genes in Zebrafish Mol. Biol. Evol., January 1, 2004; 21(1): 14 - 28. [Abstract] [Full Text] [PDF]

				D. Striimper, M. Durieux, and P. Roekaerts Endothelial and Microvascular Function Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2003; 7(3): 225 - 238. [Abstract] [PDF]

				S. G. Lalchandani, L. Lei, W. Zheng, M. M. Suni, B. M. Moore, S. B. Liggett, D. D. Miller, and D. R. Feller Yohimbine Dimers Exhibiting Selectivity for the Human alpha 2c-Adrenoceptor Subtype J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 979 - 984. [Abstract] [Full Text] [PDF]

				X. Li and J. C. Eisenach alpha 2A-Adrenoceptor Stimulation Reduces Capsaicin-Induced Glutamate Release from Spinal Cord Synaptosomes J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 939 - 944. [Abstract] [Full Text] [PDF]

				D. P. Naselsky, D. Ashton, R. R. Ruffolo Jr., and J. P. Hieble Rabbit alpha 2-Adrenoceptors: Both Platelets and Adipocytes Have alpha 2A-Pharmacology J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 219 - 225. [Abstract] [Full Text]

				S. Guimaraes and D. Moura Vascular Adrenoceptors: An Update Pharmacol. Rev., June 1, 2001; 53(2): 319 - 356. [Abstract] [Full Text] [PDF]

				V. A. Boundy and A. H. Cincotta Hypothalamic adrenergic receptor changes in the metabolic syndrome of genetically obese (ob/ob) mice Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2000; 279(2): R505 - R514. [Abstract] [Full Text] [PDF]

				T. J. Feuerstein, B. Huber, J. Vetter, H. Aranda, V. Van Velthoven, and N. Limberger Characterization of the alpha 2-Adrenoceptor Subtype, Which Functions as alpha 2-Autoreceptor in Human Neocortex J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 356 - 362. [Abstract] [Full Text]

				E. S. Vizi Role of High-Affinity Receptors and Membrane Transporters in Nonsynaptic Communication and Drug Action in the Central Nervous System Pharmacol. Rev., March 1, 2000; 52(1): 63 - 90. [Abstract] [Full Text] [PDF]

				T. Asano, S. Dohi, S. Ohta, H. Shimonaka, and H. Iida Antinociception by Epidural and Systemic {alpha}2-Adrenoceptor Agonists and Their Binding Affinity in Rat Spinal Cord and Brain Anesth. Analg., February 1, 2000; 90(2): 400 - 400. [Abstract] [Full Text] [PDF]

				D. B. Bylund and D. M. Chacko Characterization of {alpha}2 Adrenergic Receptor Subtypes in Human Ocular Tissue Homogenates Invest. Ophthalmol. Vis. Sci., September 1, 1999; 40(10): 2299 - 2306. [Abstract] [Full Text] [PDF]

				P. Chopin, F. C. Colpaert, and M. Marien Effects of Alpha-2 Adrenoceptor Agonists and Antagonists on Circling Behavior in Rats with Unilateral 6-Hydroxydopamine Lesions of the Nigrostriatal Pathway J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 798 - 804. [Abstract] [Full Text]

				D. B. Bylund, L. J. Iversen, W. J. Matulka, and D. M. Chacko J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1171 - 1177. [Abstract] [Full Text]

				S. Mhaouty, J. Cohen-Tannoudji, R. Bouet-Alard, I. Limon-Boulez, J.-P. Maltier, and C. Legrand Characteristics of the [IMAGE][IMAGE]/[IMAGE][IMAGE]-Adrenergic Receptor-coupled Adenylyl Cyclase System in Rat Myometrium during Pregnancy J. Biol. Chem., May 5, 1995; 270(18): 11012 - 11016. [Abstract] [Full Text] [PDF]